Jaysynth Orgochem Ltd
Incorporation in 1973, JD Orgochem Ltd is in the business of manufacturing and trading of dyes & chemicals[1]
- Market Cap ₹ 205 Cr.
- Current Price ₹ 15.2
- High / Low ₹ 29.2 / 14.0
- Stock P/E 13.5
- Book Value ₹ 9.54
- Dividend Yield 0.31 %
- ROCE 13.4 %
- ROE 12.6 %
- Face Value ₹ 1.00
Pros
Cons
- Company might be capitalizing the interest cost
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Commodities Chemicals Chemicals & Petrochemicals Specialty Chemicals
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2006 18m | Mar 2007 | Mar 2008 | Mar 2009 | Mar 2010 | Mar 2011 | Mar 2023 | Mar 2024 | Mar 2025 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|
| 23 | 12 | 13 | 12 | 12 | 1 | 192 | 212 | 227 | 245 | |
| 63 | 19 | 32 | 291 | 24 | 2 | 188 | 194 | 204 | 223 | |
| Operating Profit | -40 | -7 | -19 | -279 | -11 | -1 | 4 | 18 | 23 | 22 |
| OPM % | -175% | -56% | -144% | -2,295% | -93% | -67% | 2% | 8% | 10% | 9% |
| -9 | -1 | 33 | 554 | 15 | 1 | 3 | 3 | 3 | 3 | |
| Interest | 48 | 32 | 1 | 0 | 0 | 0 | 0 | 1 | 2 | 2 |
| Depreciation | 11 | 6 | 4 | 4 | 4 | 4 | 3 | 3 | 3 | 3 |
| Profit before tax | -108 | -46 | 9 | 271 | -0 | -4 | 3 | 17 | 21 | 21 |
| Tax % | 0% | 0% | 0% | 0% | 59% | 0% | 77% | 29% | 27% | |
| -108 | -46 | 9 | 271 | -0 | -4 | 1 | 12 | 16 | 15 | |
| EPS in Rs | 204.75 | -0.32 | -2.82 | 0.58 | 9.28 | 1.16 | 1.13 | |||
| Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 5% | 0% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | 14% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | 14% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 17% |
| 5 Years: | 40% |
| 3 Years: | 32% |
| 1 Year: | -39% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| Last Year: | 13% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2006 | Mar 2007 | Mar 2008 | Mar 2009 | Mar 2010 | Mar 2011 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 13 | 13 | 13 | 1 | 1 | 1 | 13 | 13 | 13 | 13 |
| Reserves | -282 | -328 | -314 | -31 | -32 | -36 | 81 | 97 | 109 | 115 |
| 344 | 368 | 336 | 59 | 49 | 53 | 50 | 49 | 46 | 47 | |
| 18 | 20 | 18 | 18 | 20 | 11 | 46 | 37 | 37 | 40 | |
| Total Liabilities | 94 | 74 | 53 | 47 | 38 | 29 | 190 | 196 | 206 | 215 |
| 68 | 52 | 31 | 27 | 23 | 20 | 21 | 23 | 22 | 23 | |
| CWIP | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 3 |
| Investments | 4 | 3 | 2 | 2 | 2 | 5 | 21 | 26 | 26 | 21 |
| 22 | 19 | 19 | 17 | 12 | 5 | 148 | 148 | 157 | 169 | |
| Total Assets | 94 | 74 | 53 | 47 | 38 | 29 | 190 | 196 | 206 | 215 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2006 | Mar 2007 | Mar 2008 | Mar 2009 | Mar 2010 | Mar 2011 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|
| 2 | -3 | -3 | 277 | 11 | -4 | 18 | 7 | 7 | |
| 1 | 9 | 33 | 0 | 0 | 0 | -10 | -6 | 1 | |
| -3 | -8 | -31 | -277 | -10 | 4 | -3 | -0 | -9 | |
| Net Cash Flow | 0 | -1 | -0 | 0 | 1 | -0 | 6 | 0 | -2 |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2006 | Mar 2007 | Mar 2008 | Mar 2009 | Mar 2010 | Mar 2011 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 61 | 130 | 198 | 121 | 122 | 0 | 87 | 83 | 75 |
| Inventory Days | 144 | 211 | 157 | 231 | 56 | 148 | 155 | 148 | 181 |
| Days Payable | 29 | 121 | 123 | 177 | 142 | 42 | 96 | 73 | 64 |
| Cash Conversion Cycle | 176 | 220 | 232 | 176 | 35 | 106 | 146 | 158 | 193 |
| Working Capital Days | 28 | -77 | 5 | -63 | -302 | -1,842 | 135 | 146 | 149 |
| ROCE % | -20% | -14% | -17% | -31% | -22% | 11% | 13% |
Documents
Announcements
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
13 Nov - Published Extract of Un-audited Standalone and Consolidated Financial Results for the quarter and half financial year ended 30th September, 2025 which appeared in "Financial Express" …
-
Approval Of Capital Expenditure
12 Nov - Board approved ₹7.75 Cr capex to add 1,800–2,000 MT inks capacity from Q4 FY2025-26.
- Submission Of Financial Results 12 Nov
-
Board Meeting Outcome for Outcome Of Board Meeting
12 Nov - Board approved unaudited standalone and consolidated results, assets/liabilities and cash flow statements for quarter/half-year ended 30 Sep 2025.
-
Announcement under Regulation 30 (LODR)-Amendments to Memorandum & Articles of Association
5 Nov - Amended MOA filed; ROC registered object-clause alterations (certificates dated 28 Jun 2024, 9 Sep 2024).
Annual reports
-
Financial Year 2025
from bse
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from nse
-
Financial Year 2012
from bse
Business Overview:[1]
Company manufactures and deals in dyes, dyes intermediates, organic chemicals, textile auxiliaries, pigments, resins, plasticizers and emulsions